Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata in elderly people is usually mild and responds well to treatment.

COVID-19 can increase the risk of hair loss, especially in people over 40.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Some people with a history of autoimmune hair loss experienced worsening symptoms after COVID-19 vaccination.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Routine eye exams may be needed for alopecia areata patients due to common eye issues.

Lupus erythematosus can mimic alopecia areata, and trichoscopy is key for accurate diagnosis and better patient outcomes.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Alopecia areata has different forms and can significantly affect quality of life, especially in more severe cases.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Younger patients and those with more hair loss are less likely to benefit from oral steroid treatment for hair loss, and low vitamin D may predict relapse.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

Dupilumab may help treat alopecia areata in children with atopic dermatitis, but it can also cause new hair loss.

Alopecia areata patients have worse quality of life, anxiety, and depression than vitiligo patients.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

Alopecia areata severity in children is linked to atopy history, disease duration, and nail involvement, but not anemia.

Alopecia Areata affects young adults more in high-income countries, especially females.

Alopecia areata patients often have autoimmune disorders, especially thyroid issues.

Alopecia areata patients are more likely to develop systemic lupus erythematosus.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Alopecia areata affects about 1.93% of people worldwide, with more women affected than men.

Alopecia areata patients have a higher risk of blood clots.

A new type of alopecia areata, called the "confetti variant," causes small bald spots that often heal on their own in a few months.